BioCentury
ARTICLE | Company News

Discovery Laboratories pulmonary news

March 23, 2015 7:00 AM UTC

Discovery Laboratories disclosed in its 2014 financial results that it will restructure to focus on development of Aerosurf aerosolized KL4 surfactant for respiratory diseases, beginning with respiratory distress syndrome (RDS) in premature infants. Discovery Labs expects to complete an ongoing Phase IIb trial of Aerosurf in the indication in 2Q16. ...